RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos Diaz Osterman to Imidazoles

Back to Details
This is a "connection" page, showing publications Carlos Diaz Osterman has written about Imidazoles.
Carlos Diaz Osterman
Connection Strength
0.123
Imidazoles
  1. de Necochea-Campion R, Diaz Osterman CJ, Hsu HW, Fan J, Mirshahidi S, Wall NR, Chen CS. AML sensitivity to YM155 is modulated through AKT and Mcl-1. Cancer Lett. 2015 Sep 28; 366(1):44-51.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support